| Document Date: 2015-01-08 11:28:42
Open Document File Size: 1,15 MBShare Result on Facebook
Company Accord Healthcare Limited / AstraZeneca UK Limited / AstraZeneca A/S / / Country Poland / Norway / Belgium / France / Austria / Netherlands / Iceland / Italy / Portugal / Bulgaria / United Kingdom / Malta / Lithuania / Cyprus / Sweden / Spain / Ireland / Denmark / / Event FDA Phase / / Facility Drug Substance INN / / IndustryTerm pharmaceutical form / generic medicinal product / reference medicinal product / pharmaceutical and biological aspects / pharmaceutical development / healthcare professionals / originator product / inspection services / pharmaceutical viewpoint / patients/healthcare professionals / medicinal product / manufacturing sites / reference products / aqueous intravenous solutions / equivalent reference product / grey bromobutyl rubber stoppers / manufacturing process / food / / MedicalCondition gastric and duodenal ulcers / acid-related disorders / esophagitis / erosive reflux esophagitis / Stomach ulcers / reflux disease / pain / duodenal ulcers / gastric ulcers / inflammation / gastroesophageal reflux disease / / Organization MHRA / European Union / / Position pharmacist / / Product Nexium / disodium edetate / omeprazole / DC / Esomeprazole / / ProgrammingLanguage EC / DC / /
SocialTag |
PAR Esomepr azole 40 mg Powder for Solution for Injection/Infusion UK/H[removed]DC Public Assessment Report Decentralised Procedure